Scott Baumgartner
Impact in
- Nephrology top 0.5%
- Gout, Hyperuricemia, Uric Acid
- Immunology top 5%
- Psoriasis: Treatment and Pathogenesis
Papers in
- Nephrology 36
- Gout, Hyperuricemia, Uric Acid 35
- Rheumatology 14
- Urticaria and Related Conditions 11
- Rheumatoid Arthritis Research and Therapies 3
- Spondyloarthritis Studies and Treatments 3
- Co-authors
- Chris Storgard (12 shared papers)Gregory Kricorian (1 shared paper)Girish Aras (1 shared paper)Maple M. Fung (13 shared papers)Alan Menter (1 shared paper)James G. Krueger (1 shared paper)Craig L. Leonardi (1 shared paper)Jean‐Paul Ortonne (1 shared paper)
- Journals
- Annals of the Rheumatic Diseases (17 papers)Lara D. Veeken (3 papers)Seminars in Arthritis and Rheumatism (2 papers)Arthritis Research & Therapy (2 papers)Inflammatory Bowel Diseases (2 papers)
- Partner nations
- United StatesNew ZealandCanada
In The Last Decade
Scott Baumgartner
51 papers receiving 2.1k citations
Scott Baumgartner's Hit Papers
Peers
Comparison fields: 5 of 94
- Nephrology 952
- Immunology 747
- Rheumatology 512
- Dermatology 258
- Pathology and Forensic Medicine 181
Countries citing papers authored by Scott Baumgartner
This map shows the geographic impact of Scott Baumgartner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Baumgartner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Baumgartner more than expected).
Fields of papers citing papers by Scott Baumgartner
This network shows the impact of papers produced by Scott Baumgartner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Baumgartner. The network helps show where Scott Baumgartner may publish in the future.
Co-authors
The 25 scholars most cited alongside Scott Baumgartner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis Hit paper breakdown → | 2012 | 761 |
| 2 | 2016 | 140 | |
| 3 | 2016 | 130 | |
| 4 | 2017 | 125 | |
| 5 | 2017 | 91 | |
| 6 | 2015 | 91 | |
| 7 | 2014 | 86 | |
| 8 | 2009 | 70 | |
| 9 | 2015 | 65 | |
| 10 | 2011 | 59 | |
| 11 | 2017 | 48 | |
| 12 | 2011 | 43 | |
| 13 | 2018 | 42 | |
| 14 | 2009 | 30 | |
| 15 | 2015 | 28 | |
| 16 | 2016 | 27 | |
| 17 | 2018 | 27 | |
| 18 | 2018 | 26 | |
| 19 | 2018 | 21 | |
| 20 | 2019 | 20 |
About Scott Baumgartner
Scott Baumgartner is a scholar working on Nephrology, Rheumatology, Molecular Biology, Surgery and Immunology, having authored 52 papers that have together received 2.1k indexed citations. Recurring topics across this work include Gout, Hyperuricemia, Uric Acid (35 papers), Urticaria and Related Conditions (11 papers), Case Reports on Hematomas (3 papers), Inflammasome and immune disorders (3 papers), Rheumatoid Arthritis Research and Therapies (3 papers), Spondyloarthritis Studies and Treatments (3 papers), Hepatitis C virus research (3 papers) and Bone and Joint Diseases (2 papers). The work is most often cited by research in Nephrology (952 citations), Immunology (747 citations), Rheumatology (512 citations), Dermatology (258 citations) and Pathology and Forensic Medicine (181 citations). Scott Baumgartner has collaborated with scholars based in United States, New Zealand and Canada. Frequent co-authors include Chris Storgard, Gregory Kricorian, Girish Aras, Maple M. Fung, Alan Menter, James G. Krueger, Craig L. Leonardi, Jean‐Paul Ortonne, Elizabeth H. Thompson and Kim Papp. Their work appears in journals such as Annals of the Rheumatic Diseases, Lara D. Veeken, Seminars in Arthritis and Rheumatism, Arthritis Research & Therapy and Inflammatory Bowel Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.